PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 5, 2026MedComm0 citationsOpen Access

Multi‐Omics Analysis in Autoimmunity: Identification of MicroRNA Regulatory Networks and Cell‐Type‐Specific Dysregulations in Multiple Sclerosis and Type 1 Diabetes

View Full Paper
JRJacopo RonchiRRR RigolioDTDavide Maria Trevisan

Key Points

  • The study aims to explore microRNA dysregulation in autoimmune diseases, specifically in multiple sclerosis and type 1 diabetes.
  • Performed multi-omics analysis of microRNA expression in CD14 + monocytes, neutrophils, and CD8 + T cells.
  • Focused on two autoimmune diseases: multiple sclerosis and type 1 diabetes.
  • Examined patterns of dysregulation specific to each immune cell type.
  • Identified distinct miRNA dysregulation patterns in each cell type.
  • T1D monocytes showed enhanced M1 polarization linked to inflammatory damage.
  • Alterations in CD8 + T cells from MS patients affected their fate commitment and apoptosis regulation.

Abstract

ABSTRACT Autoimmune diseases (AIDs) arise from complex immune dysregulations involving multiple immune cell types, cytokines, and molecular mediators. Among these, microRNAs (miRNAs) have recently emerged as key regulators of leukocyte processes and are frequently dysregulated in AIDs. However, their role in disease pathophysiology remains poorly understood. In this study, we performed a comprehensive analysis of miRNA expression in three immune populations, namely, CD14 + monocytes, neutrophils, and CD8 + T cells, in multiple sclerosis (MS) and type 1 diabetes (T1D), two prototypical AIDs. Our results reveal distinct patterns of miRNA dysregulation in each cell type, with monocytes from T1D patients showing enhanced M1 polarization and supporting inflammatory vascular damage. On the other hand, CD8 + T cells from MS patients show profound alterations related to CD8 + T cell‐fate commitment, apoptosis regulation, and migratory capacity. Notably, we identified miRNAs that regulate key transcription factors such as FOXP3, IRF4, and RORγt, potentially shaping T cell differentiation programs. Our results suggest that miRNA networks play a central role in orchestrating disease‐specific dysregulation in AIDs. By elucidating these intricate regulatory mechanisms, our study provides a foundation for future therapeutic strategies targeting miRNAs in autoimmunity.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ronchi et al. (2026) studied this question.

synapsesocial.com/papers/69d1fcd4a79560c99a0a2892https://doi.org/10.1002/mco2.70647
Ask AI
Helpful
Bookmark
Share
View Full Paper